Inovio announces collaboration with colombia; memorandum of understanding focuses on protecting against covid-19 and supporting broader health preparedness initiatives

Plymouth meeting, pa., oct. 21, 2021 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on bringing to market precisely designed dna medicines to treat and protect people from infectious diseases, cancer, and hpv-associated diseases, today announced the signing of a non-binding memorandum of understanding (mou) with colombia's ministry of health and social protection reflecting the intent to advance efforts to combat the pandemic and endemic threat posed by covid-19  and to better prepare for future public health emergencies.
INO Ratings Summary
INO Quant Ranking